Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 43

1.

Management of oxidative stress and other pathologies in Alzheimer's disease.

Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M, Valko M.

Arch Toxicol. 2019 Aug 22. doi: 10.1007/s00204-019-02538-y. [Epub ahead of print] Review.

PMID:
31440798
2.

Synthesis, structural characterization, EPR spectroscopy and Hirshfeld surface analysis of a novel Cu2+-doped 3,14-diethyl-2,13-diaza-6,17-diazoniatricyclo[16.4.0.07,12]docosane bis(perchlorate).

Moncol J, Mazúr M, Valko M, Choi JH.

Acta Crystallogr C Struct Chem. 2019 Jun 1;75(Pt 6):616-622. doi: 10.1107/S2053229619005588. Epub 2019 May 14.

PMID:
31166912
3.

Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.

Simunkova M, Lauro P, Jomova K, Hudecova L, Danko M, Alwasel S, Alhazza IM, Rajcaniova S, Kozovska Z, Kucerova L, Moncol J, Svorc L, Valko M.

J Inorg Biochem. 2019 May;194:97-113. doi: 10.1016/j.jinorgbio.2019.02.010. Epub 2019 Feb 23.

PMID:
30849593
4.

Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon.

Kuca K, Jun D, Junova L, Musilek K, Hrabinova M, da Silva JAV, Ramalho TC, Valko M, Wu Q, Nepovimova E, França TCC.

Molecules. 2018 May 7;23(5). pii: E1103. doi: 10.3390/molecules23051103.

5.

Protective role of quercetin against copper(II)-induced oxidative stress: A spectroscopic, theoretical and DNA damage study.

Jomova K, Lawson M, Drostinova L, Lauro P, Poprac P, Brezova V, Michalik M, Lukes V, Valko M.

Food Chem Toxicol. 2017 Dec;110:340-350. doi: 10.1016/j.fct.2017.10.042. Epub 2017 Oct 26.

PMID:
29107026
6.

Targeting Free Radicals in Oxidative Stress-Related Human Diseases.

Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M.

Trends Pharmacol Sci. 2017 Jul;38(7):592-607. doi: 10.1016/j.tips.2017.04.005. Epub 2017 May 24. Review.

PMID:
28551354
7.

MRI assessment of bone structure and microarchitecture.

Chang G, Boone S, Martel D, Rajapakse CS, Hallyburton RS, Valko M, Honig S, Regatte RR.

J Magn Reson Imaging. 2017 Aug;46(2):323-337. doi: 10.1002/jmri.25647. Epub 2017 Feb 6. Review.

8.

Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer's disease using multifunctional tacrine-coumarin hybrid molecules.

Hamulakova S, Poprac P, Jomova K, Brezova V, Lauro P, Drostinova L, Jun D, Sepsova V, Hrabinova M, Soukup O, Kristian P, Gazova Z, Bednarikova Z, Kuca K, Valko M.

J Inorg Biochem. 2016 Aug;161:52-62. doi: 10.1016/j.jinorgbio.2016.05.001. Epub 2016 May 5.

PMID:
27230386
9.

Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.

Valko M, Jomova K, Rhodes CJ, Kuča K, Musílek K.

Arch Toxicol. 2016 Jan;90(1):1-37. doi: 10.1007/s00204-015-1579-5. Epub 2015 Sep 7. Review.

PMID:
26343967
10.

Calculations of hyperfine coupling constant of copper(II) in aqueous environment. Finite temperature molecular dynamics and relativistic effects.

Malček M, Bučinský L, Valko M, Biskupič S.

J Mol Model. 2015 Sep;21(9):237. doi: 10.1007/s00894-015-2752-8. Epub 2015 Aug 18.

PMID:
26280985
11.

Synthesis, crystal structure, spectroscopic properties and potential biological activities of salicylate‒neocuproine ternary copper(II) complexes.

Kucková L, Jomová K, Švorcová A, Valko M, Segľa P, Moncoľ J, Kožíšek J.

Molecules. 2015 Jan 27;20(2):2115-37. doi: 10.3390/molecules20022115.

12.

EPR spectroscopy of a clinically active (1:2) copper(II)-histidine complex used in the treatment of Menkes disease: a Fourier transform analysis of a fluid CW-EPR spectrum.

Gala L, Lawson M, Jomova K, Zelenicky L, Congradyova A, Mazur M, Valko M.

Molecules. 2014 Jan 15;19(1):980-91. doi: 10.3390/molecules19010980.

13.

Health protective effects of carotenoids and their interactions with other biological antioxidants.

Jomova K, Valko M.

Eur J Med Chem. 2013;70:102-10. doi: 10.1016/j.ejmech.2013.09.054. Epub 2013 Oct 6. Review.

PMID:
24141200
14.

Outlier detection for patient monitoring and alerting.

Hauskrecht M, Batal I, Valko M, Visweswaran S, Cooper GF, Clermont G.

J Biomed Inform. 2013 Feb;46(1):47-55. doi: 10.1016/j.jbi.2012.08.004. Epub 2012 Aug 27.

15.

Redox cycling mechanisms in the colon.

Jomova K, Valko M.

Med Hypotheses. 2012 Sep;79(3):418-9. doi: 10.1016/j.mehy.2012.05.012. Epub 2012 Jun 7. No abstract available.

PMID:
22683236
16.

Identification of microbial and proteomic biomarkers in early childhood caries.

Hart TC, Corby PM, Hauskrecht M, Hee Ryu O, Pelikan R, Valko M, Oliveira MB, Hoehn GT, Bretz WA.

Int J Dent. 2011;2011:196721. doi: 10.1155/2011/196721. Epub 2011 Oct 16.

17.

Importance of iron chelation in free radical-induced oxidative stress and human disease.

Jomova K, Valko M.

Curr Pharm Des. 2011;17(31):3460-73. Review.

PMID:
21902663
18.

A tetranuclear copper(II) cluster: bis(μ-4-chlorobenzoato-κ2O:O')(4-chlorobenzoato-κ2O,O')(4-chlorobenzoato-κO)tetrakis(μ3-2-pyridylmethanolato-κ4N,O:O:O)tetracopper(II).

Moncol J, Jomova K, Zelenicky L, Lis T, Valko M.

Acta Crystallogr C. 2011 Sep;67(Pt 9):m318-20. doi: 10.1107/S010827011103335X. Epub 2011 Aug 31.

PMID:
21881181
19.

Advances in metal-induced oxidative stress and human disease.

Jomova K, Valko M.

Toxicology. 2011 May 10;283(2-3):65-87. doi: 10.1016/j.tox.2011.03.001. Epub 2011 Mar 23. Review.

PMID:
21414382
20.

Conditional outlier detection for clinical alerting.

Hauskrecht M, Valko M, Batal I, Clermont G, Visweswaran S, Cooper GF.

AMIA Annu Symp Proc. 2010 Nov 13;2010:286-90.

Supplemental Content

Loading ...
Support Center